Filing Details
- Accession Number:
- 0001474064-11-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-10 11:53:30
- Reporting Period:
- 2011-11-09
- Filing Date:
- 2011-11-10
- Accepted Time:
- 2011-11-10 11:53:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
890465 | Nps Pharmaceuticals Inc | NPSP | Biological Products, (No Disgnostic Substances) (2836) | 870439579 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192128 | M Luke Beshar | 550 Hills Drive Bedminster NJ 07921 | Svp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-09 | 20,000 | $5.36 | 22,639 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the purchase of 20,000 shares in 14 separate transactions, ranging from $5.32 to $5.37 per share, resulting in a weighted average purchase price per share of $5.3572. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.
- Includes 2,639 shares of stock obtained through the Issuer's Employee Stock Purchase Plan.